GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis

NASDAQ:GEHC • US36266G1076

83.4401 USD
-0.61 (-0.73%)
Last: Feb 25, 2026, 10:57 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, GEHC scores 4 out of 10 in our fundamental rating. GEHC was compared to 185 industry peers in the Health Care Equipment & Supplies industry. GEHC has an excellent profitability rating, but there are concerns on its financial health. GEHC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year GEHC was profitable.
  • In the past year GEHC had a positive cash flow from operations.
  • GEHC had positive earnings in 4 of the past 5 years.
  • Of the past 5 years GEHC 4 years had a positive operating cash flow.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of GEHC (6.14%) is better than 85.41% of its industry peers.
  • GEHC has a Return On Equity of 22.19%. This is amongst the best in the industry. GEHC outperforms 95.68% of its industry peers.
  • GEHC has a better Return On Invested Capital (7.77%) than 83.24% of its industry peers.
  • GEHC had an Average Return On Invested Capital over the past 3 years of 8.36%. This is in line with the industry average of 8.75%.
Industry RankSector Rank
ROA 6.14%
ROE 22.19%
ROIC 7.77%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 10.95%, GEHC belongs to the best of the industry, outperforming 84.86% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GEHC has grown nicely.
  • Looking at the Operating Margin, with a value of 13.52%, GEHC belongs to the top of the industry, outperforming 81.62% of the companies in the same industry.
  • GEHC's Operating Margin has been stable in the last couple of years.
  • GEHC has a Gross Margin of 40.80%. This is in the lower half of the industry: GEHC underperforms 67.03% of its industry peers.
  • In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
Industry RankSector Rank
OM 13.52%
PM (TTM) 10.95%
GM 40.8%
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • GEHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • GEHC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.93 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.93, GEHC perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • The Debt to FCF ratio of GEHC is 7.38, which is on the high side as it means it would take GEHC, 7.38 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.38, GEHC is in the better half of the industry, outperforming 74.59% of the companies in the same industry.
  • GEHC has a Debt/Equity ratio of 0.83. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
  • GEHC has a Debt to Equity ratio of 0.83. This is in the lower half of the industry: GEHC underperforms 72.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 7.38
Altman-Z 1.93
ROIC/WACC0.81
WACC9.64%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • GEHC has a Current Ratio of 1.18. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.18, GEHC is doing worse than 81.62% of the companies in the same industry.
  • A Quick Ratio of 0.95 indicates that GEHC may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.95, GEHC is not doing good in the industry: 78.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.95
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.00% over the past year.
EPS 1Y (TTM)2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.13%

3.2 Future

  • Based on estimates for the next years, GEHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.96% on average per year.
  • The Revenue is expected to grow by 3.10% on average over the next years.
EPS Next Y9.67%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
EPS Next 5Y8.96%
Revenue Next Year4.34%
Revenue Next 2Y4.43%
Revenue Next 3Y4.08%
Revenue Next 5Y3.1%

3.3 Evolution

GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.22, the valuation of GEHC can be described as rather expensive.
  • Based on the Price/Earnings ratio, GEHC is valued cheaply inside the industry as 84.86% of the companies are valued more expensively.
  • GEHC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 16.61, GEHC is valued correctly.
  • GEHC's Price/Forward Earnings ratio is rather cheap when compared to the industry. GEHC is cheaper than 85.95% of the companies in the same industry.
  • GEHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.01.
Industry RankSector Rank
PE 18.22
Fwd PE 16.61
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaply inside the industry as 84.86% of the companies are valued more expensively.
  • 82.70% of the companies in the same industry are more expensive than GEHC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 27.16
EV/EBITDA 13.49
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GEHC does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)1.88
PEG (5Y)N/A
EPS Next 2Y10.7%
EPS Next 3Y10.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.18%, GEHC is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.20, GEHC pays a better dividend. On top of this GEHC pays more dividend than 89.73% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, GEHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 2.80% of the earnings are spent on dividend by GEHC. This is a low number and sustainable payout ratio.
DP2.8%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (2/25/2026, 10:57:08 AM)

83.4401

-0.61 (-0.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners89.01%
Inst Owner Change3.54%
Ins Owners0.28%
Ins Owner Change0.19%
Market Cap38.03B
Revenue(TTM)N/A
Net Income(TTM)2.22B
Analysts78.57
Price Target94.06 (12.73%)
Short Float %2.19%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-09
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.54%
Min EPS beat(2)-0.16%
Max EPS beat(2)13.24%
EPS beat(4)3
Avg EPS beat(4)8.5%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)5.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.55%
PT rev (3m)5.97%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE 18.22
Fwd PE 16.61
P/S 1.88
P/FCF 27.16
P/OCF 20.56
P/B 3.81
P/tB N/A
EV/EBITDA 13.49
EPS(TTM)4.58
EY5.49%
EPS(NY)5.02
Fwd EY6.02%
FCF(TTM)3.07
FCFY3.68%
OCF(TTM)4.06
OCFY4.86%
SpS44.42
BVpS21.93
TBVpS-10.12
PEG (NY)1.88
PEG (5Y)N/A
Graham Number47.53
Profitability
Industry RankSector Rank
ROA 6.14%
ROE 22.19%
ROCE 10.51%
ROIC 7.77%
ROICexc 9.18%
ROICexgc 27.2%
OM 13.52%
PM (TTM) 10.95%
GM 40.8%
FCFM 6.91%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexgc growth 3Y-14.77%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 7.38
Debt/EBITDA 2.51
Cap/Depr 78.67%
Cap/Sales 2.22%
Interest Coverage 5.09
Cash Conversion 55.91%
Profit Quality 63.15%
Current Ratio 1.18
Quick Ratio 0.95
Altman-Z 1.93
F-Score5
WACC9.64%
ROIC/WACC0.81
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.69%
EPS Next Y9.67%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
EPS Next 5Y8.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.13%
Revenue Next Year4.34%
Revenue Next 2Y4.43%
Revenue Next 3Y4.08%
Revenue Next 5Y3.1%
EBIT growth 1Y8.91%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year18.38%
EBIT Next 3Y10.76%
EBIT Next 5Y9.55%
FCF growth 1Y-18.75%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-11.61%
OCF growth 3Y6.68%
OCF growth 5Y1.2%

GE HEALTHCARE TECHNOLOGY / GEHC FAQ

What is the fundamental rating for GEHC stock?

ChartMill assigns a fundamental rating of 4 / 10 to GEHC.


What is the valuation status for GEHC stock?

ChartMill assigns a valuation rating of 6 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Fairly Valued.


How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?

GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.


What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?

The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.


Can you provide the dividend sustainability for GEHC stock?

The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 2.8%.